When something constantly occupies your attention, it ends up influencing your decisions. That’s why, if you spend a large part of the day thinking about food, it becomes very difficult not to give in to cravings. That internal monologue about what to eat or when to eat it, whether you should start the diet next Monday, whether it was a good idea to eat that piece of chocolate, or how many calories you’ve consumed creates mental noise that works against you.
In fact, recently someone who has been using Mounjaro vial for a couple of months to lose weight told me that one of the things that surprised them most was that they no longer thought about food constantly. “It’s like they flipped a switch in my head,” they said. And they weren’t wrong, because tirzepatide, the active ingredient in this medication, can “hack” the brain to help us stop thinking about food.
“Food noise” is not just a metaphor
“Food noise” isn’t those fleeting thoughts that appear when we have to organize dinner or the occasional craving for a chocolate cake or a pizza with extra cheese. It’s a persistent flow of ideas about food that becomes a constant, invasive, and difficult-to-ignore mental presence.
This causes food to occupy a disproportionate space in our minds, as if we were always “tuned” to the same channel, which often conditions our behavior.
In neuropsychological terms, this mental noise consists of neural processes that cause certain stimuli (like a food advertisement or thinking about a sweet treat) to persistently activate brain circuits related to reward, attention, and motivation, even when we aren’t physiologically hungry.
Food noise has been reported by people who suffer from obesity, eating disorders involving loss of control (such as binge eating or bulimia nervosa), or who use food to manage their emotions.
What happens is that certain brain regions, primarily the nucleus accumbens and other parts of the mesolimbic reward system, become highly sensitive to food stimuli, generating intrusive thoughts and a strong predisposition to respond to them impulsively.
How do weight-loss medications silence food noise?
Initially, it was thought that GLP-1 analogues, such as Ozempic and Wegovy, and dual GLP-1/GIP agonists, such as Mounjaro, slowed stomach emptying, so people felt full faster and for longer. It was believed that satiety was what lessened the recurring thoughts about food.
However, everything seems to indicate that these medications go a step further, crossing the blood-brain barrier and actually acting on different areas of the brain.
Recently, a pioneering study published in Nature Medicine directly recorded the brain activity of three severely obese individuals who struggled to control their eating habits using electrodes.
Neuroscientists discovered that episodes of intense preoccupation with food and cravings were linked to low-frequency brain signals (delta-theta activity) in the nucleus accumbens. They also found that tirzepatide reduced cravings and thoughts about food by decreasing delta-theta brainwave activity.
The nucleus accumbens is a key brain region in the reward system, involved in motivation, pleasure, and the pursuit of rewarding stimuli. When we think about food and experience a strong desire to eat, this circuit is activated with specific patterns of electrical activity.
Essentially, tirzepatide reduces the aberrant signaling in the nucleus accumbens associated with compulsive eating. In other words, the neural circuits that are usually activated whenever we think about food don’t “switch on” excessively while we’re under the influence of the medication.
At a psychological level, this has two important implications:
1. It reduces the intensity of intrusive thoughts. The stimuli that previously triggered a cascade of automatic thoughts about food no longer monopolize our attention.
2. Greater cognitive control. By decreasing background noise, the brain has more resources available for executive functions, which means we can assess whether we’re truly hungry, choose healthier options, and regulate our behavior more consciously.
It’s not a magic bullet – and it doesn’t last forever
Basically, neuroscience tells us that “food noise” has a real biological basis and that, like other brain functions, it can be modulated pharmacologically, although we don’t yet fully understand the mechanisms or the long-term effects of these novel obesity medications.
This discovery offers hope, in even to treat other psychological disorders. In fact, obesity drugs are already being tested to address addictions to drugs, alcohol, and nicotine since they share neuropsychological mechanisms.
However, it is important to have realistic expectations. Neuroscientists also found that the silencing effect on food cravings was temporary. After a few months, neural activity returned to previous levels, even though the person continued with the treatment.
It is likely that, like many other psychotropic drugs, the brain will eventually get used to it, and what is known as habituation will occur. On the other hand, it is also crucial to keep in mind that, although weight-loss medications like Ozempic, Wegovy, and Mounjaro can alter the brain signals associated with compulsive eating, they do not act directly on the root of long-term thought patterns. Medications act on reward and motivation circuits for a time, but deeply ingrained cognitive patterns and emotional conditioning linked to food may require psychological intervention to achieve lasting behavioral changes.
In particular, I consider these medications an initial aid for people who struggle to start losing weight because they feel trapped in a mental loop of food-related noise and bad habits, but not as a substitute for psychonutrition.
Medications like Mounjaro can momentarily silence that “internal radio” that keeps talking about food, giving you space to think more clearly and act with more control, but the journey toward a balanced relationship with food and your emotions remains a task that involves both biology and mind. And that means developing good eating habits and changing your relationship with food.
References:
Dhurandhar, E.J. et. Al. (2025) Food noise: definition, measurement, and future research directions. Nutr. Diabetes; 15: 30.
Choi, W. et. Al. (2025) Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide. Nat Med; 31: 4038–4043.
O’Keefe, J. H. et.(2025) Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy. Progress in Cardiovascular Diseases; 89: 102-112.
Kalivas, P. W. et. Al. (2023) Intrusive thinking: Circuit and synaptic mechanisms of a transdiagnostic psychiatric symptom. Neuroscience & Biobehavioral Reviews; 150: 105196.
Leave a Reply